Items Tagged ‘Indolent/Low Grade Non-Hodgkin’s Lymphoma’

February 10, 2012

Two Different Approaches to Rituxan Both Effective For Follicular Lymphoma

By

Among patients with low-tumor-burden follicular lymphoma who have received initial treatment with Rituxan® (rituximab), waiting until disease progression to take additional Rituxan is as effective as ongoing, maintenance Rituxan. These results were presented at the 53rd Annual meeting of the American Society of Hematology. Follicular lymphoma is an indolent (slow-growing) type of non-Hodgkin’s lymphoma. It […]

View full entry

Tags: Indolent/Low Grade Non-Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma


November 10, 2008

Addition of Zevalin® to Chemotherapy Effective for Follicular NHL

By

Addition of Zevalin® to Chemotherapy Effective for Follicular NHL Administration of Zevalin® (Y-ibritumomab tiuxetan) immediately following initial chemotherapy for advanced follicular lymphoma improves progression-free survival for two years compared with chemotherapy alone. These results were recently published in the Journal of Clinical Oncology. Non-Hodgkin®s lymphoma (NHL) is a form of cancer that begins in the […]

View full entry

Tags: Indolent/Low Grade Non-Hodgkin's Lymphoma


September 29, 2008

Survival Rates Improving in Childhood Hematologic Cancers

By

Survival Rates Improving in Childhood Hematologic Cancers Five- and 10-year survival rates in childhood hematalogic cancers have significantly improved since 1990, according to the results of a study recently published in the Journal of the National Cancer Institute. Approximately 40% of childhood cancers are classified as hematalogic cancers. Hematologic cancers are cancers of the blood […]

View full entry

Tags: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Stage Hodgkin's Lymphoma, Aggressive/Intermediate Grade Non-Hodgkin's Lymphoma, Early Stage Hodgkin's Lymphoma, Highly Aggressive/High Grade Non-Hodgkin's Lymphoma, Indolent/Low Grade Non-Hodgkin's Lymphoma